| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K88742110 | CTRPv2 | pan-cancer | AAC | -0.078 | 0.04 |
| mRNA | GSK2126458 | GDSC1000 | pan-cancer | AAC | -0.066 | 0.04 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | 0.068 | 0.04 |
| mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | 0.07 | 0.04 |
| mRNA | AGK-2 | CTRPv2 | pan-cancer | AAC | -0.081 | 0.04 |
| mRNA | PF-543 | CTRPv2 | pan-cancer | AAC | -0.08 | 0.04 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.069 | 0.04 |
| mRNA | BRD-K63431240 | CTRPv2 | pan-cancer | AAC | -0.076 | 0.04 |
| mRNA | BRD-K29313308 | CTRPv2 | pan-cancer | AAC | -0.078 | 0.04 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | -0.066 | 0.04 |